Cargando...
Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention
There is an increasing appreciation that complement dysregulation lies at the heart of numerous immune-mediated and inflammatory disorders. Complement inhibitors are therefore being evaluated as new therapeutic options in various clinical translation programs and the first clinically approved comple...
Guardado en:
| Publicado en: | Mol Oral Microbiol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4712080/ https://ncbi.nlm.nih.gov/pubmed/26332138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/omi.12129 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|